Atıf Formatları
Novelties in the management of B-cell malignancies: B-cell receptor signaling inhibitors and lenalidomide
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. Salihoglu Et Al. , "Novelties in the management of B-cell malignancies: B-cell receptor signaling inhibitors and lenalidomide," EXPERT REVIEW OF HEMATOLOGY , vol.8, no.6, pp.765-783, 2015

Salihoglu, A. Et Al. 2015. Novelties in the management of B-cell malignancies: B-cell receptor signaling inhibitors and lenalidomide. EXPERT REVIEW OF HEMATOLOGY , vol.8, no.6 , 765-783.

Salihoglu, A., Ar, M. C., & Soysal, T., (2015). Novelties in the management of B-cell malignancies: B-cell receptor signaling inhibitors and lenalidomide. EXPERT REVIEW OF HEMATOLOGY , vol.8, no.6, 765-783.

Salihoglu, Ayşe, Muhlis Cem AR, And Teoman SOYSAL. "Novelties in the management of B-cell malignancies: B-cell receptor signaling inhibitors and lenalidomide," EXPERT REVIEW OF HEMATOLOGY , vol.8, no.6, 765-783, 2015

Salihoglu, Ayşe Et Al. "Novelties in the management of B-cell malignancies: B-cell receptor signaling inhibitors and lenalidomide." EXPERT REVIEW OF HEMATOLOGY , vol.8, no.6, pp.765-783, 2015

Salihoglu, A. Ar, M. C. And Soysal, T. (2015) . "Novelties in the management of B-cell malignancies: B-cell receptor signaling inhibitors and lenalidomide." EXPERT REVIEW OF HEMATOLOGY , vol.8, no.6, pp.765-783.

@article{article, author={Ayşe SALİHOĞLU Et Al. }, title={Novelties in the management of B-cell malignancies: B-cell receptor signaling inhibitors and lenalidomide}, journal={EXPERT REVIEW OF HEMATOLOGY}, year=2015, pages={765-783} }